Publications by authors named "N L Crosby"
Article Synopsis
- This study examines the financial effects on healthcare payers of using 60-day peripheral nerve stimulation (60-Day PNS) compared to a conventional brief trial (PNS-BT) for chronic pain patients.
- Analysis of Medicare data revealed that patients starting with 60-Day PNS had lower costs and fewer complications when progressing to permanent implants compared to those starting with PNS-BT.
- Overall, the 60-Day PNS approach is more cost-effective, resulting in lower costs per successful treatment outcome for chronic pain management.
Objective: The present IRB-approved retrospective chart review describes the use of a 60-day PNS treatment for shoulder pain at a single center in 60 total consecutive patients.
Background: Chronic shoulder pain affects an increasing number of patients per year and is especially prevalent in elderly populations. Percutaneous peripheral nerve stimulation (PNS) treatment targeting the nerves of the shoulder has been shown to reduce pain in prospective clinical studies and in analysis of real-world data.
This real-world analysis aims to quantify improvements in multiple health domains in patients who received 60-day peripheral nerve stimulation (PNS) for shoulder pain. Patients reported percent pain relief and Patient Global Impression of Change in quality of life, physical function and sleep at the end of treatment (EOT), 3 months, and 6 months. Of 768 patients, 80.
View Article and Find Full Text PDFConventionally, peripheral nerve stimulation (PNS) for treatment of chronic pain has involved a two-stage process: a short-term (e.g., 7 days) trial and, if significant pain relief is achieved, a permanent PNS system is implanted.
View Article and Find Full Text PDF